Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06090578 · ClinicalTrials.gov registry record · NA

TabCAT Brain Health Assessment in Primary Care

A NA study of Mild Cognitive Impairment and Dementia, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
180,000
Enrollment target
1
Study location

NCT06090578 is a NA study of Mild Cognitive Impairment and Dementia that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 180,000 participants, above the 392-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (45818% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06090578, a NA study of Mild Cognitive Impairment and Dementia, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
180,000 participants
Enrollment target
1
Study location

Study Summary

Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic cluster randomized trial in 26 Kaiser Southern California primary care clinics.

Interventions

  • OTHER TabCAT Brain Health Assessment Clinical Pathway

Study Locations (1)

California

  • Kaiser Permanente Southern California Department of Research & Evaluation - Pasadena

Trial Details

FieldValue
Enrollment Target 180,000 participants
Start Date 2023-07-27
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT06090578

The ClinicalTrials.gov registry entry for NCT06090578 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 392-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (45818% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which TabCAT Brain Health Assessment Clinical Pathway is the first listed.

NCT06090578 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06090578 about?

NCT06090578 is a clinical study titled "TabCAT Brain Health Assessment in Primary Care". Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the e...

What is the current status of trial NCT06090578?

This trial is currently recruiting. It is a NA study. The enrollment target is 180,000 participants. The study started on 2023-07-27. Estimated completion is 2026-12-31.

What conditions does trial NCT06090578 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia.

What interventions are being tested in trial NCT06090578?

The interventions under investigation include: TabCAT Brain Health Assessment Clinical Pathway (OTHER).

Who is sponsoring clinical trial NCT06090578?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06090578 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.